Scientists establish completely new route to cancer development



A large proteomics study on the brains of newborn mice provides more evidence that numbing drugs often used in obstetric or pediatric medicine can have profound and long-term negative effects, even after minimal exposure. This study, appearing in the December issue of Molecular and Cellular Proteomics , highlights the delicate state of the developing nervous

Full Post: Numbing drugs can have profound and long-term negative effects

CANCER RESEARCH UK scientists have linked cancer clues in faulty cells to provide a new route to cancer development, reveals a study published in Developmental Cell.

Cancer is a disease caused by uncontrolled cell growth and division and understanding the complex molecular networks inside cells which regulate these processes is fundamental to understanding what goes wrong in cancer.

Researchers at the University of Liverpool used flies to understand how cell growth and division is controlled. Many of the proteins found in fly cells are also present in human cells and since fly cells are less complicated and grow faster than human cells they are easier to study and enable scientists to see changes more quickly.

They linked together pieces of a complex puzzle inside fly cells to show that signals from outside the cell are fed through a protein called pico - which has an equivalent protein called Lamellipodin in humans. This process ultimately regulates cell growth and division and understanding it will help improve our knowledge of how cancer develops.

This research unravels for the first time an intricate new pathway which helps explain the biochemistry behind a broad range of cancers.

Lead author, Cancer Research UK scientist Dr Ekaterina Lyulcheva, who is based at the University of Liverpool, said: “Before now, scientists knew about the presence of these molecules and their possible link to cancer, but no one knew how they talked to each other, to ultimately control tissue growth.”

Laboratory head and corresponding author Dr Daimark Bennett, also based at the University of Liverpool said: “We are extremely excited to have unlocked the key to a completely new route to cancer development and hope it will kick start a whole new direction for powerful research projects to block points in this pathway through the development of new drugs.”

The scientists made the connection that a cell signalling molecule called epidermal growth factor receptor (EGFR), which has already been implicated in driving cancers, sends messages to the pico β?” or Lamellipodin proteins.

Cancers driven by EGFR include breast cancer, ovarian cancer and cancers of the head and neck.

Lesley Walker, director of cancer information at Cancer Research UK, said: “Finding out more about cell growth and division will ultimately help us understand how cancer develops and how we can more accurately target drugs to beat it.

“This important basic research shows we have succeeded in taking another critical step towards piecing together the jigsaw of how cancer develops.”

Link




CANCER RESEARCH UK scientists have shown how bowel cancer can become aggressive, according to research published in Nature Genetics. The researchers, based in the Cardiff School of Biosciences, Cardiff University and at Cancer Research UK’s Beatson Institute in Glasgow found that a tumour suppressor protein called Pten is critical in stopping tumours from growing in

Full Post: Scientists find a trigger to aggressive bowel cancer



Cancer and cell biology experts at the University of Cincinnati (UC) have identified a new tumor suppressor that may help scientists develop more targeted drug therapies to combat lung cancer. The study, led by Jorge Moscat, PhD, appears in the January 2009 issue of Molecular and Cellular Biology . Proto-oncogenes are genes that play a

Full Post: Discovery of new tumor suppressor for lung cancer



A Florida State University College of Medicine research team led by Yanchang Wang has discovered an important new layer of regulation in the cell division cycle, which could lead to a greater understanding of the way cancer begins. Wang, an assistant professor of biomedical sciences at the College of Medicine, said the findings will lead

Full Post: Scientists discover an important new layer of regulation in the cell division cycle



Two critical properties of cancer cells are their ability to divide without restraint and to spread away from the primary tumor to establish new tumor sites. Now, researchers from the Mayo Clinic campus in Florida have found a protein they say acts as a deadly master switch, both freeing cancer cells from a tumor while

Full Post: Scientists identify dangerous ‘two-faced’ protein crucial to breast cancer spread and growth



Once-promising drugs that were abandoned in the fight against breast cancer still could be effective in obese patients, new research suggests. In laboratory tests, hormones produced by fat cells stimulate breast cancer cells to migrate and invade surrounding tissues, scientists at Emory University School of Medicine found. A class of drugs called epithelial growth factor

Full Post: EGFR inhibitors show promise for obesity